Yuyu Pharm to work with KRICT on joint development of ischemic vascular drugs
Published: 2004-07-14 06:56:00
Updated: 2004-07-14 06:56:00
Yuyu Pharm said on July 9 it has signed with the Korea Research Institute of Chemical and Technology a strategic agreement to jointly develop new drugs for the treatment of ischemic vascular diseases such as myocardial infarction, ischemia and arrhythmia.
Under the agreement, Yuyu will be allo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
